Osaic Holdings
FTXH icon

Osaic Holdings’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Osaic Holdings’s Portfolio FTXH Stock Details FTXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$60.5K Sell
1,762
-849
-33% -$29K ﹤0.01% 5057
2025
Q4 		$86K Sell
2,611
-421
-14% -$13.1K ﹤0.01% 4840
2025
Q3 		$84.3K Sell
3,032
-265
-8% -$7.21K ﹤0.01% 4928
2025
Q2 		$84.5K Sell
3,297
-451
-12% -$11.4K ﹤0.01% 4644
2025
Q1 		$103K Buy
3,748
+1,298
+53% +$35.9K ﹤0.01% 4142
2024
Q4 		$66.1K Buy
2,450
+250
+11% +$7.02K ﹤0.01% 4496
2024
Q3 		$63.4K Buy
2,200
+425
+24% +$12.2K ﹤0.01% 4569
2024
Q2 		$48.4K Sell
1,775
-573
-24% -$15.3K ﹤0.01% 4703
2024
Q1 		$65.8K Sell
2,348
-505
-18% -$13.9K ﹤0.01% 4536
2023
Q4 		$75.9K Sell
2,853
-2,011
-41% -$50.7K ﹤0.01% 4612
2023
Q3 		$124K Sell
4,864
-382
-7% -$10.1K ﹤0.01% 4338
2023
Q2 		$137K Sell
5,246
-900
-15% -$23.8K ﹤0.01% 4200
2023
Q1 		$161K Buy
6,146
+183
+3% +$4.91K ﹤0.01% 4048
2022
Q4 		$164K Buy
5,963
+5
+0.1% +$133 ﹤0.01% 4034
2022
Q3 		$142K Hold
5,958
– – ﹤0.01% 4063
2022
Q2 		$158K Buy
5,958
+33
+0.6% +$872 ﹤0.01% 4018
2022
Q1 		$217K Sell
5,925
-1,702
-22% -$44K ﹤0.01% 3962
2021
Q4 		$207K Sell
7,627
-1,061
-12% -$27.9K ﹤0.01% 3908
2021
Q3 		$224K Buy
8,688
+80
+0.9% +$2.1K ﹤0.01% 3803
2021
Q2 		$223K Sell
8,608
-1,719
-17% -$44.4K ﹤0.01% 3775
2021
Q1 		$264K Buy
10,327
+695
+7% +$18.2K ﹤0.01% 3495
2020
Q4 		$248K Buy
9,632
+2,785
+41% +$69.3K ﹤0.01% 3278
2020
Q3 		$165K Buy
6,847
+4,615
+207% +$111K ﹤0.01% 3414
2020
Q2 		$50K Buy
2,232
+141
+7% +$3.12K ﹤0.01% 4179
2020
Q1 		$41K Buy
+2,091
New +$45.6K ﹤0.01% 4124

Other funds holding FTXH

LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return
MIM
Marshall Investment Management Littleton, Colorado $208M AUM 30.96% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
AIP
Ameritas Investment Partners Lincoln, Nebraska $3.25B AUM 28.52% 1-Year Est. Return
NP
Nilsine Partners Greenwood Village, Colorado $1.45B AUM 47.06% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
VCM
Vivaldi Capital Management Chicago, Illinois $723M AUM 30.89% 1-Year Est. Return

Osaic Holdings's FTXH Position: Q1 2026 in Review

Osaic Holdings reduced its First Trust Nasdaq Pharmaceuticals ETF (FTXH) stake by 33% in Q1 2026, selling an estimated $29K and leaving 1,762 shares worth $60.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5057.

Osaic Holdings first reported a position in FTXH in Q1 2020 and has held it in 25 quarters since. The position peaked at $264K in Q1 2021. 32 funds tracked by Wall St. Rank hold FTXH as of Q1 2026.

  • Osaic Holdings held 1,762 shares of First Trust Nasdaq Pharmaceuticals ETF worth $60.5K as of Q1 2026.
  • Osaic Holdings sold 849 First Trust Nasdaq Pharmaceuticals ETF shares in Q1 2026, an estimated $29K.
  • First Trust Nasdaq Pharmaceuticals ETF made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #5057 holding.
  • Osaic Holdings first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's First Trust Nasdaq Pharmaceuticals ETF position peaked at $264K in Q1 2021.
  • 32 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.